These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16284188)

  • 21. Alternative UPS drug targets upstream the 26S proteasome.
    Hjerpe R; Rodríguez MS
    Int J Biochem Cell Biol; 2008; 40(6-7):1126-40. PubMed ID: 18203645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concise review: role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells.
    Naujokat C; Sarić T
    Stem Cells; 2007 Oct; 25(10):2408-18. PubMed ID: 17641241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation.
    Sun L; Trausch-Azar JS; Ciechanover A; Schwartz AL
    Oncogene; 2007 Jan; 26(3):441-8. PubMed ID: 16909127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Renaissance of vascular endothelial growth factor, part B.
    Schaper W
    Circ Res; 2008 Oct; 103(9):903-4. PubMed ID: 18948625
    [No Abstract]   [Full Text] [Related]  

  • 25. Exploring proteasome complexes by proteomic approaches.
    Drews O; Zong C; Ping P
    Proteomics; 2007 Apr; 7(7):1047-58. PubMed ID: 17390294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
    Zhao H; Liao Y; Minamino T; Asano Y; Asakura M; Kim J; Asanuma H; Takashima S; Hori M; Kitakaze M
    Hypertens Res; 2008 Oct; 31(10):1977-87. PubMed ID: 19015605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiology of the ubiquitn sytstem: overview].
    Tanaka K
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1261-5. PubMed ID: 16922384
    [No Abstract]   [Full Text] [Related]  

  • 29. SUMOylation: a novel protein quality control modifier in the heart.
    Maejima Y; Sadoshima J
    Circ Res; 2014 Sep; 115(8):686-9. PubMed ID: 25258400
    [No Abstract]   [Full Text] [Related]  

  • 30. Application and analysis of the GFPu family of ubiquitin-proteasome system reporters.
    Bence NF; Bennett EJ; Kopito RR
    Methods Enzymol; 2005; 399():481-90. PubMed ID: 16338377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune therapy against tumors based on the ubiquitin-proteasome pathway].
    Himeno K; Hisaeda H
    Fukuoka Igaku Zasshi; 2007 Aug; 98(8):312-9. PubMed ID: 17907447
    [No Abstract]   [Full Text] [Related]  

  • 32. A genetic screen for Saccharomyces cerevisiae mutants affecting proteasome function, using a ubiquitin-independent substrate.
    Hoyt MA; McDonough S; Pimpl SA; Scheel H; Hofmann K; Coffino P
    Yeast; 2008 Mar; 25(3):199-217. PubMed ID: 18260085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible function of caudal nuclear pocket: degradation of nucleoproteins by ubiquitin-proteasome system in rat spermatids and human sperm.
    Haraguchi CM; Mabuchi T; Hirata S; Shoda T; Tokumoto T; Hoshi K; Yokota S
    J Histochem Cytochem; 2007 Jun; 55(6):585-95. PubMed ID: 17312012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory roles of the ubiquitin-proteasome system in cardiomyocyte apoptosis.
    Sohns W; van Veen TA; van der Heyden MA
    Curr Mol Med; 2010 Feb; 10(1):1-13. PubMed ID: 20205676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ubiquitin proteasome system in human cardiomyopathies and heart failure.
    Day SM
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1283-93. PubMed ID: 23479263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
    Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW
    Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome inhibition: mechanism of action.
    DeMartino GN
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction.
    Guo W; Jung WE; Marionneau C; Aimond F; Xu H; Yamada KA; Schwarz TL; Demolombe S; Nerbonne JM
    Circ Res; 2005 Dec; 97(12):1342-50. PubMed ID: 16293790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nuclear ubiquitin-proteasome system.
    von Mikecz A
    J Cell Sci; 2006 May; 119(Pt 10):1977-84. PubMed ID: 16687735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac plasticity.
    Hill JA; Olson EN
    N Engl J Med; 2008 Mar; 358(13):1370-80. PubMed ID: 18367740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.